UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 324

Sortiert nach

Combined GS-4774 and tenofovir therapy can improve HBV-specific T cell responses in patients with chronic active hepatitis B

Journal of hepatology, 2017, Vol.66 (1), p.S29-S29

2017

Volltextzugriff (PDF)

Proteasome dysfunction as a reversible defect underlying virus-specific CD8 cell exhaustion in chronic hepatitis B

Journal of hepatology, 2017, Vol.66 (1), p.S30-S30

2017

Volltextzugriff (PDF)

Clinical spectrum of cryoglobulinaemic neuropathy

Journal of neurology, neurosurgery and psychiatry, 2005-10, Vol.76 (10), p.1410-1414

2005

Volltextzugriff (PDF)

P187 INNATE ANTIVIRAL RESPONSES IN HBeAg NEGATIVE PATIENTS WITH CHRONIC HEPATITIS B (CH-B) UNDER LONG-TERM NUCLEOS(T)IDE ANALOGUE (NUC) TREATMENT: IMPLICATIONS FOR FUTURE IMMUNE THERAPIES

Journal of hepatology, 2014-04, Vol.60 (1), p.S128-S128

2014

Volltextzugriff (PDF)

O103 TRANSCRIPTOME ANALYSIS OF EXHAUSTED VIRUS-SPECIFIC CD8 T CELLS IN CHRONIC HBV INFECTION IDENTIFIES PROFOUND METABOLIC AND FUNCTIONAL CELL DEFECTS

Journal of hepatology, 2014-04, Vol.60 (1), p.S42-S42

2014

Volltextzugriff (PDF)

Hepatitis delta virus (HDV) coinfection among patients with HBsAg positive cirrhosis. An analysis the MASTER-B cohort

Digestive and liver disease, 2014-10, Vol.46, p.e135-e135

2014

Volltextzugriff (PDF)

Epidemiological evolution of Chronic Hepatitis Delta in Italy. An analysis of the Master-B cohort

Digestive and liver disease, 2014-02, Vol.46, p.e12-e13

2014

Volltextzugriff (PDF)

524 RESPONSE-GUIDED PEGINTERFERON ALFA-2A THERAPY BASED ON HBSAG LEVELS AT WEEK 12 AND WEEK 24 OR 48 IMPROVES RESPONSE RATES IN HBEAG-NEGATIVE, GENOTYPE D PATIENTS

Journal of hepatology, 2012-04, Vol.56, p.S207-S208

2012

Volltextzugriff (PDF)

764 ENTECAVIR EFFECTIVENESS IN DAILY CLINICAL PRACTICE, INTERIM ANALYSIS OF THE ITALIAN Master-Entas COHORT STUDY OF PATIENTS WITH CHRONIC HEPATITIS B

Journal of hepatology, 2013-04, Vol.58, p.S311-S311

2013

Volltextzugriff (PDF)

730 PEGBELIVER STUDY: HBSAG DECLINE AT WEEK 24 OF EXTENDED PEGINTERFERON ALFA-2A (PEG-IFNα-2A) THERAPY IS SIGNIFICANTLY ASSOCIATED WITH POST-TREATMENT RESPONSE IN HBEAG-NEGATIVE GENOTYPE D PATIENTS

Journal of hepatology, 2011-03, Vol.54, p.S293-S293

2011

Volltextzugriff (PDF)

T-14 Interim analysis of the Italian Master-Entas cohort study: entecavir effectiveness in field practice for chronic hepatitis B

Digestive and liver disease, 2013-02, Vol.45, p.S17-S18

2013

Volltextzugriff (PDF)

98 EXTENDED (2 YEARS) TREATMENT WITH PEGINTERFERON ALFA-2A [40KD] IMPROVES SUSTAINED RESPONSE RATES IN GENOTYPE D PATIENTS WITH HBEAG NEGATIVE CHRONIC HEPATITIS B

Journal of hepatology, 2010, Vol.52, p.S45-S45

2010

Volltextzugriff (PDF)

558 RESTORATION OF VIRUS SPECIFIC T CELL MEMORY IN CHRONIC HBV INFECTION: IMPLICATIONS FOR OPTIMIZATION OF ANTIVIRAL-THERAPY

Journal of hepatology, 2009, Vol.50, p.S206-S206

2009

Volltextzugriff (PDF)

5 EXHAUSTION AND FUNCTIONAL RESTORATION OF INTRAHEPATIC HBV-SPECIFIC T CELLS IN CHRONIC HEPATITIS B

Journal of hepatology, 2008, Vol.48, p.S4-S5

2008

Volltextzugriff (PDF)

Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection

The Journal of immunology (1950), 1990-11, Vol.145 (10), p.3442

1990

Volltextzugriff (PDF)

T.N.18 THE HBV-SPECIFIC T CELL FUNCTION CAN BE RECONSTITUTED IN CHRONIC HBV INFECTION: IMPLICATIONS FOR IMMUNE THERAPIES

Digestive and liver disease, 2010, Vol.42, p.S21-S21

2010

Volltextzugriff (PDF)

[125] PD-1/PD-L BLOCKADE CAN IMPROVE THE HBV-SPECIFIC T CELL FUNCTION IN CHRONIC HBV INFECTION

Journal of hepatology, 2007, Vol.46, p.S56-S56

2007

Volltextzugriff (PDF)

Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen

The Journal of clinical investigation, 1991-07, Vol.88 (1), p.214-222

1991

Volltextzugriff (PDF)

PS-053 - Proteasome dysfunction as a reversible defect underlying virus-specific CD8 cell exhaustion in chronic hepatitis B

Journal of hepatology, 2017, Vol.66 (1), p.S30-S30

2017

Volltextzugriff (PDF)

PS-050 - Combined GS-4774 and tenofovir therapy can improve HBV-specific T cell responses in patients with chronic active hepatitis B

Journal of hepatology, 2017, Vol.66 (1), p.S29-S29

2017

Volltextzugriff (PDF)

Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B

Gut, 2013-02, Vol.62 (2), p.290-298

2013

Volltextzugriff (PDF)

Oral lichen planus pathogenesis: A role for the HCV-specific cellular immune response

Hepatology (Baltimore, Md.), 2002-12, Vol.36 (6), p.1446-1452

2002

Volltextzugriff (PDF)

Missed treatment in an Italian HBV infected patients cohort: HBV RER

Digestive and liver disease, 2016-11, Vol.48 (11), p.1346-1350

2016

Volltextzugriff (PDF)

Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B

The Journal of immunology (1950), 1987-09, Vol.139 (6), p.2050

1987

Volltextzugriff (PDF)

Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha

The American journal of medicine, 1996-11, Vol.101 (5), p.482-487

1996

Volltextzugriff (PDF)

1 – 25 von 324

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(294)
Mit Volltextzugriff
(289)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Combined GS-4774 and tenofovir therapy can improve HBV-specific T cell responses in patients with chronic active hepatitis B

Proteasome dysfunction as a reversible defect underlying virus-specific CD8 cell exhaustion in chronic hepatitis B

Clinical spectrum of cryoglobulinaemic neuropathy

P187 INNATE ANTIVIRAL RESPONSES IN HBeAg NEGATIVE PATIENTS WITH CHRONIC HEPATITIS B (CH-B) UNDER LONG-TERM NUCLEOS(T)IDE ANALOGUE (NUC) TREATMENT: IMPLICATIONS FOR FUTURE IMMUNE THERAPIES

O103 TRANSCRIPTOME ANALYSIS OF EXHAUSTED VIRUS-SPECIFIC CD8 T CELLS IN CHRONIC HBV INFECTION IDENTIFIES PROFOUND METABOLIC AND FUNCTIONAL CELL DEFECTS

Hepatitis delta virus (HDV) coinfection among patients with HBsAg positive cirrhosis. An analysis the MASTER-B cohort

Epidemiological evolution of Chronic Hepatitis Delta in Italy. An analysis of the Master-B cohort

524 RESPONSE-GUIDED PEGINTERFERON ALFA-2A THERAPY BASED ON HBSAG LEVELS AT WEEK 12 AND WEEK 24 OR 48 IMPROVES RESPONSE RATES IN HBEAG-NEGATIVE, GENOTYPE D PATIENTS

764 ENTECAVIR EFFECTIVENESS IN DAILY CLINICAL PRACTICE, INTERIM ANALYSIS OF THE ITALIAN Master-Entas COHORT STUDY OF PATIENTS WITH CHRONIC HEPATITIS B

730 PEGBELIVER STUDY: HBSAG DECLINE AT WEEK 24 OF EXTENDED PEGINTERFERON ALFA-2A (PEG-IFNα-2A) THERAPY IS SIGNIFICANTLY ASSOCIATED WITH POST-TREATMENT RESPONSE IN HBEAG-NEGATIVE GENOTYPE D PATIENTS

T-14 Interim analysis of the Italian Master-Entas cohort study: entecavir effectiveness in field practice for chronic hepatitis B

98 EXTENDED (2 YEARS) TREATMENT WITH PEGINTERFERON ALFA-2A [40KD] IMPROVES SUSTAINED RESPONSE RATES IN GENOTYPE D PATIENTS WITH HBEAG NEGATIVE CHRONIC HEPATITIS B

558 RESTORATION OF VIRUS SPECIFIC T CELL MEMORY IN CHRONIC HBV INFECTION: IMPLICATIONS FOR OPTIMIZATION OF ANTIVIRAL-THERAPY

5 EXHAUSTION AND FUNCTIONAL RESTORATION OF INTRAHEPATIC HBV-SPECIFIC T CELLS IN CHRONIC HEPATITIS B

Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection

T.N.18 THE HBV-SPECIFIC T CELL FUNCTION CAN BE RECONSTITUTED IN CHRONIC HBV INFECTION: IMPLICATIONS FOR IMMUNE THERAPIES

[125] PD-1/PD-L BLOCKADE CAN IMPROVE THE HBV-SPECIFIC T CELL FUNCTION IN CHRONIC HBV INFECTION

Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen

PS-053 - Proteasome dysfunction as a reversible defect underlying virus-specific CD8 cell exhaustion in chronic hepatitis B

PS-050 - Combined GS-4774 and tenofovir therapy can improve HBV-specific T cell responses in patients with chronic active hepatitis B

Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B

Oral lichen planus pathogenesis: A role for the HCV-specific cellular immune response

Missed treatment in an Italian HBV infected patients cohort: HBV RER

Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B

Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha

Suchergebnisse filtern